Both in Pharmaceuticals
SCYNEXIS vs Biote
Over the past year SCYX returned −32.1% and BTMD returned −59.4%; their daily moves had a correlation of -0.06.
SCYX −32.1% BTMD −59.4%Growth of $1, one year, split-adjusted
| Metric | SCYX | BTMD |
|---|---|---|
| Price | $3.73 | $1.13 |
| Market cap | $37.1M | $32.4M |
| Today | −3.37% | −3.42% |
| 1 month | −30.5% | −2.6% |
| 6 months | −52.9% | −48.4% |
| Year to date | −26.3% | −56.5% |
| 1 year | −32.1% | −57.7% |
| Revenue growth (YoY) | −82.8% | −9.5% |
| Gross margin | 100.0% | 65.4% |
| Net margin | 3147.7% | −14.8% |
| P/E (TTM) | — | 5.5× |
| Price / sales | 1.9× | 0.2× |
| Net cash | $54.1M | -$110.3M |
| Dividend yield | — | — |
| Volatility (60d) | 64.3% | 69.3% |
| Short % of float | 4.7% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).